Some of the ongoing research directions include: Long-term safety and efficacy: As BPC-157 is a relatively new compound, long-term studies are needed to establish its safety and efficacy in various populations and for different indications
Combined, the three peptides support tissue repair from different angles at once
It could enhance intellectual capacity in lower doses
About 1-2% of people develop sensitivity
Stress management: Practices like meditation, yoga, and adequate sleep reduce stress-related inflammation
In general, but not necessarily, the homozygous variant, often the minor allele, may confer to the affected individual a higher susceptibility in comparison with the homozygous wild-type and heterozygous condition, particularly in the occupational context wherein the exposure to chemical and physical agents may worsen the disorder